AMLX20260918C5
AMLX Sep 18 2026 5.00 Call (AMLX260918C00005000)
option OPRA

Amylyx Pharmaceuticals, Inc is a biopharmaceutical company headquartered in Cambridge, Massachusetts. Amylyx is best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis.